Top Clinical Trials companies in Sweden by Gross Profit

This ranking features the top 18 Clinical Trials companies in Sweden ranked by Gross Profit, totalling a Gross Profit of USD 49.55 M, for January 15, 2025.
#
Name
Gross Profit
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 51.95 M
Dec. 31, 2023 USD 17.87 3.09%

Sweden

2
USD 7.05 M
Dec. 31, 2023 USD 2.74 1.67%

Sweden

3
USD 7.00 M
Dec. 31, 2023 USD 2.91 -2.20%

Sweden

4
USD 2.81 M
Dec. 31, 2023 USD 0.71 -2.02%

Sweden

5
USD 2.80 M
Dec. 31, 2023 USD 0.84 -0.17%

Sweden

6
USD 1.11 M
Dec. 31, 2023 USD 0.23 11.53%

Sweden

7
USD 295.80 K
Dec. 31, 2023 USD 0.28 -7.61%

Sweden

8
USD 259.64 K
Dec. 31, 2023 USD 0.11 1.51%

Sweden

9
USD 144.40 K
Dec. 31, 2023 USD 0.39 2.53%

Sweden

10
USD 102.15 K
Dec. 31, 2023 USD 0.10 0.68%

Sweden

11
USD 5.23 K
Dec. 31, 2023 USD 1.17 -3.73%

Sweden

12
USD 296.10
Dec. 31, 2023 USD 0.45 23.08%

Sweden

13
USD -346.90 K
Aug. 31, 2024 USD 1.61 0.34%

Sweden

14
USD -1.79 M
Dec. 31, 2023 USD 0.80 0.68%

Sweden

15
USD -2.10 M
Dec. 31, 2023 USD 0.21 0.68%

Sweden

16
USD -3.40 M
Dec. 31, 2023 USD 0.20 1.12%

Sweden

17
USD -4.24 M
Aug. 31, 2024 USD 0.22 -6.29%

Sweden

18
USD -12.11 M
Dec. 31, 2023 USD 0.90 9.88%

Sweden

Frequently Asked Questions
  • Which Clinical Trials company in Sweden has the highest Gross Profit ?

    The Clinical Trials company in Sweden with the highest Gross Profit is BioArctic AB (publ) (Stockholm Stock Exchange: BIOA-B.ST) at USD 51.95 M.

  • Which Clinical Trials company in Sweden has the lowest Gross Profit ?

    The Clinical Trials company in Sweden with the lowest Gross Profit is IRLAB Therapeutics AB (publ) (Stockholm Stock Exchange: IRLAB-A.ST) at USD -12.11 M.